NCT05560139

Brief Summary

This work is aimed to assess the long term effect of TDCS in fatigue management among MS patients

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable multiple-sclerosis

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 29, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

September 29, 2022

Status Verified

September 1, 2022

Enrollment Period

5 months

First QC Date

May 18, 2022

Last Update Submit

September 24, 2022

Conditions

Keywords

Multiple sclerosisTranscranial direct current stimulationfatigue

Outcome Measures

Primary Outcomes (2)

  • fatigue assessment scale

    it is a acale filed by the patient and it consists of scale from 1 to 10

    at post sessions, 1 month and 2 month post sessions

  • visual analogue scale

    it is a scale from 0 to 10 to assess major fatigue

    at post sessions, 1 month and 2 month post sessions

Secondary Outcomes (1)

  • changes in cortical excitability parameters at post 10th session compared to baseline measurements of cortical excitability parameters

    at post sessions, 1 month and 2 month post sessions

Study Arms (2)

experimental group

EXPERIMENTAL

Participants in the experimental groups received ten -sessions a-tDCS (1.5mA, 20minutes) anodal stimulation of left DLPC over two weeks duration (five sessions per week).

Device: a-tDCS

sham group

SHAM COMPARATOR

The sham group received ten sessions of sham stimulation for 20-minutes in each session.

Device: a-tDCS

Interventions

a-tDCSDEVICE

Transcranial direct current stimulation

experimental groupsham group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Any adult patient will be fulfilling diagnostic criteria of Multiple sclerosis and could be providing consent for participation in the study, will be included in the study.

You may not qualify if:

  • any patient showed this following condition will be excluded from the study;
  • Any MS patient had any contraindication condition to use TMS or TCDS (such as epilepsy, head trauma, metallic procedure, cerebral insult)
  • Any patient had infection or febrile condition.
  • Any patient had other co morbid neurological or psychiatric disorders or systemic disease.
  • Any patient refuses participation in study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Multiple SclerosisFatigue

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Noha M Abo-Elfetoh, PHD

    Assiut University

    STUDY CHAIR

Central Study Contacts

Entsar karem, resident

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Anodal, or sham with a ratio 1:1 were placed in serially numbered opaque closed envelopes. Each patient was given a serial number from a computer generated randomization table, and was placed in the appropriate group after opening the corresponding sealed envelope.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized clinical trial-controlled study to assess the ability of tDCS; anodal stimulation of left DLPC versus sham stimulation in improving fatigue in MS patients
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 18, 2022

First Posted

September 29, 2022

Study Start

December 1, 2022

Primary Completion

May 1, 2023

Study Completion

September 1, 2023

Last Updated

September 29, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL